-
COMITÉ CIENTÍFICO Y ORGANIZADOR: Dres. Enrique Aman, Claudio Martín, José Menéndez
COMITÉ ORGANIZADOR y CIENTÍFICO
INVITADOS INTERNACIONALES
Dr. Delvys Rodriguez Abreu
España
I am a board-certified medical oncologist specialized in thoracic malignancies. My background includes training in Internal Medicine and Medical Oncology at the National Institute of Oncology in Havana, Cuba, and a Clinical and Research Fellowship at the Oncology Institute of Southern Switzerland, and in the Catalan Institute of Oncology in Barcelona. At present, I serve as the director of Medical Oncology Department at the Hospital Universitario Insular of Gran Canaria, Spain, and as associate professor of medicine at the University of Gran Canaria. I am member of ASCO, ESMO, IASLC and SEOM and member of the board of directors of the SLCG and GETICA. I have published several peer-reviewed articles in addition to abstracts and book chapters. Researchgate: https://www.researchgate.net/profile/Delvys-Rodriguez-Abreu
Dra. Isabelle Opitz
Suiza
Personal information Prof. Dr. Med. Isabelle Schmitt-Opitz Director of Department of Thoracic Surgery Professor/Ordinaria for Thoracic Surgery, University of Zurich Chair Lung Cancer Center Zurich University Hospital Zurich Raemistrasse 100, 8091 Zurich +41 44 255 88 01 isabelle.schmitt-opitz@usz.ch ORCID: 0000-0001-5900-9040, ResearcherID: R-6011-2017 2. Education 1980 – 1984 Städtische Katholische Grundschule Köln 1984 – 1992 Erzbischöfliches Gymnasium, Liebfrauenschule Köln 01.01.2001 M.D. (1999 Drittes Staatsexamen, 1999-2001 Arzt im Praktikum) 2005 Board title for General Surgery 2008 Habilitation 2011 6 years SNSF-Professorship 2013 European Board of Thoracic Surgery 2014 FMH Thoraxchirurgie 2017 Professura ad personam UZH 2022 Professor/Ordinaria for Thoracic Surgery, UZH 3. Employment history including current position(s) 1999 –2002 Residency, Division of General-, Visceral-, Vascular-, and Thoracic Surgery at Humboldt University Berlin, Campus Charité Mitte, 10117 Berlin, D 2002 –2003 Resident and Chief Resident, Division of General Surgery, Cantonal Hospital, Fribourg, CH 2003 Resident Trauma Surgery, University Hospital Zurich, CH 2004 – 2007 Resident Department of Thoracic Surgery, University Hospital Zurich, CH 2011 Fellowship in Thoracic Surgery, University of Toronto, Faculty of Medicine, Department of Surgery, CA 2014 – 2015 Specialized training at the Marie Lannelongue Centre Chirurgical, Paris 2007 - ongoing Department of Thoracic Surgery, University Hospital Zurich, Staff surgeon, 2015 Senior Staff Surgeon, 2020 Director of Department 4. Institutional responsibilities Director of the Department of Thoracic Surgery, University Hospital Zurich Head Research Thoracic Surgery, University Hospital Zurich Chair Lung Cancer Center Zurich 5. Approved research projects Total of grants received exceeds 11 Mio CHF (thereof more than 10 Mio CHF as PI) 6. Supervision of junior researchers at graduate and postgraduate level Master students (10 completed, 8 ongoing), Dissertation students (10 completed, 6 ongoing), PhD students (1 completed, 2 ongoing), Master of Biology for M.D. (1 completed) and Post-Doc (1 completed, 2 ongoing), Research Fellows (3 completed, 1 ongoing) 7. Teaching activities • Lecturer at University of Zurich since 2005 for different surgical courses • Expert / Supervisor for state examinations • European School of Oncology - CAS in Lung Cancer 2018-2019 and 2020-2021 • European School of Molecular Oncology (ESO-ESMO) Masterclass 2021 • European Society for Thoracic Surgeons (ESTS) learning affairs committee and lecturer for courses in thoracic surgery 8. Memberships in panels, boards, etc., and individual scientific reviewing activities SNSF research council and Steering Committee IICT; Chair Mesothelioma Group ETOP; Treasurer, President elect and Member Learning Affair Committee ESTS; Editorial Board ATS; Taskforce Mesothelioma, Staging Subcommittee MPM and N status for NSCLC IASLC; Board Member iMig; Stiftungsrat Schulthessklinik; International Director of AATS. Reviewer for multiple scientific journals 9. Active memberships in scientific societies, fellowships in renowned academies AATS, DGC, DGT, ERS, ESMO, ESTS, ETOP, IASLC, iMig, ISHLT, SAKK, SGC, SGPH, SGT, STS 10. Organization of conferences Annual Meeting of European Society of Thoracic Surgeons (ESTS) program committee International Association of the Study of Lung Cancer (IASLC) program committee International Mesothelioma interest group (iMig) program committee International Society of Heart and Lung Transplantation (ISHLT) program committee American Association for Thoracic Surgery (AATS) program committee Member AATS International Thoracic Surgical Oncology Summit (ITSOS) program committee member 11. Prizes, awards, fellowships Young Investigator’s Award European Association for Cardiothoracic Surgery in 2006, Brompton Prize ESTS in 2007, ESMO Research Fellowship Award in 2007, IBAS Young Investigator Award in 2010, SNSF travel grant in 2010, Science award of the Walter and Gertrud Siegenthaler Foundation of the University of Zurich in 2014, Robert J. Ginsberg Lectureship Award for Surgery by IASLC in 2022, and awarded for best posters, best publications at national and international conferences. 12. Career breaks Maternity leave for 4 months in 2004/5, 6 months in 2009/10
Dra. María E. Arcilia
EE. UU.
Director, Diagnostic Molecular Pathology Laboratory. Memorial Sloan Kettering Cancer Center. Deputy Chief, Molecular Diagnostic Service. Department of Pathology and Laboratory Medicine. Memorial Sloan Kettering Cancer Center. BA, Biology/ Chemistry, Queens College, City University of NY. New York, NY. MD, University of Pittsburgh School of Medicine, Pittsburgh, PA. PROFESSIONAL ORGANIZATIONS AND SOCIETY MEMBERSHIPS. Association for Molecular Pathology (AMP). AMP Teaching and Education Committee Solid Tumor Representative. Primary Care Curriculum Task Force. NGS Validation Guidelines Task Force. Lung Cancer guidelines task force. Clonality and MRD guidelines task force. Hematopathology Subdivision. Association for Molecular Pathology. American Society for Investigative Pathology. American Society of Clinical Oncology (ASCO). College of American Pathologists. American Association of Clinical Research. European Hematology Association International Association for the Study of Lung Cancers. Association for Molecular Pathology Primary Care Curriculum Working Group. Centers for Medicare and Medicaid Services Advisory Panel
RESEARCH. My primary research focuses on the application of genomic technology in the assessment of solid tumors and hematologic malignancies. I work closely with our clinical collaborators in combining new medical content with emerging technologies, addressing specific needs for test development, technology adaptations and clinical validation of the assays before they can be used in a clinical setting. Our group has developed and implemented several comprehensive genomic profiling assays that are unique, providing un-paralleled capabilities in support of routine clinical care, research and clinical trials. As a molecular pathologist and hematopathologist, I also have shared interests in both solid tumor and hematologic malignancies and maintain active research collaborations in both fields. In solid tumors, I concentrate primarily on lung cancer and the study of genetic alterations driving neoplastic development, their assessment, targetability, and acquired resistance mechanisms following targeted therapies.
Dr. Gerard A. Silvestri
EE. UU.
Senior Vice-Chair of Faculty Development. Hillenbrand Distinguished University Professor. Division of Pulmonary and Critical Care Medicine Medical University of South Carolina, Charleston.
Dr. Silvestri is the Hillenbrand Professor of Thoracic Oncology at the Medical University of South Carolina. He completed his training in Pulmonary and Critical Care Medicine and received an additional degree in health services research, both at Dartmouth. He is widely regarded as an international expert in lung cancer. His research includes screening for lung cancer, lung nodule evaluation, diagnosis and staging of lung cancer, development of biomarkers for disease risk and treatment, and disparities in delivering lung cancer care to underserved communities. Dr. Silvestri is a writer and editor of the American College of Chest Physicians lung cancer guidelines. He has authored more than 280 scientific articles, book chapters and editorials. He has served on multiple editorial boards and currently serves on the editorial board of the journal Chest. Dr. Silvestri is past president of the American College of Chest Physicians (CHEST), a society serving 20,000 chest physicians worldwide. He currently serves on the steering committee of the American Cancer Society’s National Lung Cancer Roundtable. Dr. Silvestri was the recipient of the 2020 lifetime achievement award in Lung Cancer from the American Thoracic Society. In 2022, Dr. Silvestri was named a Master Fellow of the American College of Chest Physicians, a distinction awarded to only 40 members in the nearly 90 years of that organization existence.
Programa
PROGRAMA
08:00 - 08:50hs. (UTC-3)
ACREDITACIÓN / REGISTRATION
08:50 - 09:00hs. (UTC-3)
PALABRAS INICIALES / WELCOME REMARKS
Dr. Walter Mattarucco
Vicepresidente / Vicepresident AAMR
Dr. José Menéndez
Comité Organizador / Organizing Commitee
09:00 - 09:30hs. (UTC-3)
SCREENING EN CÁNCER DE PULMÓN. GUIAS NACIONALES/SCREENING IN LUNG CANCER. NATIONAL GUIDES
Disertante /Speaker: Dra. Iris Boyeras
09:30 - 10:00hs. (UTC-3)
DEBATE: COMO IMPLEMENTAR PROGRAMAS DE SCREENING/HOW TO IMPLEMENT SCREENING PROGRAMS
Coordinadora / Moderator: Dra. Iris Boyeras Navarro
Disertantes / Speakers: Dres. Gustavo Lyons, Gerard Silvestri, Jose Morero, Delvys Rodriguez Abreu
10:00 - 10:30hs. (UTC-3)
ENFERMEDAD OLIGO METASTÁSICA. ROL DEL CIRUJANO Y MANEJO ACTUAL/OLIGO METASTATIC DISEASE. ROLE OF THE SURGEON AND CURRENT MANAGEMENT
Coordinadores / Moderators: Dres. Tamara Portas, Lorena Lupinacci, Sergio Benitez
Disertante / Speaker: Dra. Isabelle Opitz
10:30 - 11:00hs. (UTC-3)
COFFEE BREAK
11:00 - 12:00hs. (UTC-3)
SIMPOSIO DE LA INDUSTRIA: EL APORTE DE LA INMUNOTERAPIA DUAL EN 1LNSCLC: CASOS DE LA VIDA REAL / THE VALUE OF DUAL IMMUNOTHERAPY IN 1LNSCLC: REAL-LIFE CASES
Presidente / President: Dr. Claudio Martin
Disertante / Speaker: Dr. Diego Kaen
12:00 - 12:30hs. (UTC-3)
ROL DEL NEUMONOLOGO EN LA OBTENCION DEL TEJIDO PARA ANALISIS MUTACIONALES / ROLE OF THE PNEUMONOLOGIST IN OBTAINING TISSUE FOR MUTATIONAL ANALYSIS
Coordinadores / Moderators: Dres. Juan Manuel Luchelli, Mercedes Raya
Disertante / Speaker: Dr. Gerard Silvestri
12:30 - 13:15hs. (UTC-3)
NUEVAS OPCIONES EN ADYUVANCIA (TKI/IO) / NEW OPTIONS IN ADJUVANT (TKI/IO)
Coordinadores / Moderators: Dres. Nicolás Castagnaris, Nicolás Minatta, Carmen Pupareli
Disertante / Speaker: Dr. Delvys Rodriguez Abreu
13:15 - 14:15hs. (UTC-3)
SIMPOSIO DE LA INDUSTRIA: CÁNCER DE PULMON EN LA VIDA REAL: NUEVOS PARADIGMAS / LUNG CANCER IN REAL LIFE: NEW PARADIGMS
Disertantes / Speakers: Dres. Gonzalo Recondo, Jose Menéndez, Veronica Bengió, Sergio Benítez
14:15 - 14:45hs. (UTC-3)
OPORTUNIDADES Y DESAFÍOS PARA LA IMPLEMENTACIÓN DE PRUEBAS MOLECULARES INTEGRALES QUE CUMPLEN CON CARACTERISTICAS ESTABLECIDAS / OPPORTUNITIES AND CHALLENGES FOR IMPLEMENTING COMPREHENSIVE MOLECULAR TESTING THAT COMPLIES WITH ESTABLISHED GUIDELINES
Coordinadores / Moderators: Dres. Liliana Dalurzo, Elina Karo
Disertante / Speaker: Dra. Maria E. Arcilia
14:45 - 15:15hs. (UTC-3)
COFFEE BREAK
15:15 - 16:15hs. (UTC-3)
SIMPOSIO DE LA INDUSTRIA: Controversias en el abordaje CPCNP temprano (Cáncer de Pulmón Células No Pequeñas) / Advances and controversies in the management of early stage non-small cell lung cancer
Disertantes / Speakers: Dres.Claudio Martin, Adolfo Rosales
16:15 - 16:45hs. (UTC-3)
EVALUACION Y MANEJO DEL NODULO PULMONAR / EVALUATION AND MANAGEMENT OF THE PULMONARY NODULE
Coordinadores / Moderators: Dres. Eduardo Eskenazi, Graciela Svelitza, Gabriela Wulfson
Disertante / Speaker: Dr. Gerard Silvestri
16:45 - 17:15hs. (UTC-3)
COMO SELECCIONAR LA MEJOR ESTRATEGIA EN PRIMERA LINEA SIN DRIVERS / HOW TO SELECT THE BEST STRATEGY IN THE FIRST LINE WITHOUT DRIVERS
Coordinadores / Moderators: Dres. Virginia Bluthgen, Diego Kaen, Rubén Kowalyszyn
Disertante / Speaker: Dr. Delvys Rodriguez Abreu
Cierre de sesiones
08:30 - 09:00hs. (UTC-3)
ACREDITACIÓN / REGISTRATION
09:00 - 09:30hs. (UTC-3)
RESECCIONES EXTENDIDAS LUEGO DE LA INDUCCIÓN EN ESTADIO III / EXTENDED RESECTIONS AFTER STAGE III INDUCTION
Coordinadores / Moderators: Dres. Hernán Pfeiffer, Sebastián Lamot, Marcelo Tatangelo
Disertante / Speaker: Dra. Isabelle Opitz
09:30 - 10:00hs. (UTC-3)
USO DE DNA LIBRE EN FLUIDOS CORPORALES, MAS ALLA DE PLASMA, PARA PERFIL MOLECULAR EN TUMORES DE PULMÓN / USE OF CELL FREE DNA FROM BODY FLUIDS, BEYOND PLASMA, FOR MOLECULAR PROFILING OF LUNG TUMORS
Coordinadores / Moderators: Dras. Gabriela Acosta Haab, Claudia Poleri
Disertante / Speaker: Dra. Maria E. Arcilia
10:00 - 10:30hs. (UTC-3)
NUEVOS DRIVERS.CUANDO INICIAR CON TKI Y CUANDO NO. KRAS, NTRK, MET, RET / NEW DRIVERS. WHEN TO START WITH TKI AND WHEN NOT. KRAS, NTRK, MET, RET
Coordinadores / Moderators: Dres. Florencia Tsou, Gonzalo Di Mario, Susana Sena
Disertante / Speaker: Dr. Delvys Rodriguez Abreu
10:30 - 11:00hs. (UTC-3)
COFFEE BREAK
11:00 - 12:00hs. (UTC-3)
SIMPOSIO DE LA INDUSTRIA: Abordaje Multidisciplinario del paciente con Cáncer de Pulmón en Estadios Tempranos / Multidisciplinary approach for Early Stage Lung Cancer
Coordinador / Moderator: Dr. Alejandro Videla
Disertantes / Speakers: Dres. Lisandro Paganini, Carmen Pupareli, Domingo Chimondeguy
12:00 - 12:30hs. (UTC-3)
AVANCES Y DESAFIOS EN BRONCOSCOPIA PARA EL DIAGNOSTICO EN CANCER DE PULMÓN / ADVANCES AND CHALLENGES IN BRONCHOSCOPY FOR DIAGNOSING LUNG CANCER
Coordinadores / Moderators: Dres. Patricia Vujacich, Gerardo Vilas, Rodolfo Navarrete
Disertante / Speaker: Dr. Gerard Silvestri
12:30 - 13:00hs. (UTC-3)
MESOTELIOMA. NUEVAS OPCIONES / MALIGNANT PLEURAL MESOTHELIOMA. UPDATE NEW OPTIONS
Coordinadores / Moderators: Dres. Agustín Dietrich, Carlos Donoso, Virginia Bluthgen
Disertante / Speaker: Dra. Isabelle Optiz
13:00 - 14:00hs. (UTC-3)
SIMPOSIO DE LA INDUSTRIA: NGS en cáncer de pulmón ALK+ como ejemplo de oncología de precisión / NGS in the Clinical Management of Patients with NSCLC: ALK rearrengement as an example of precision oncology
Disertantes / Speakers: Dr .Gonzalo Recondo, Dra. Julieta Pandolfi
14:00 - 14:30hs. (UTC-3)
ESTABLECIMIENTO DE PRUEBAS DE RUTINA DE ADN LIBRE DE CELULAS EN LÍQUIDO CEFALO RAQUIDEO EN PACIENTES CON CANCER DE PULMON Y COMPROMISO DEL SISTEMA NERVIOSO / ESTABLISHMENT OF ROUTINE TESTING OF CELL FREE DNA FROM CSF IN PATIENTS WITH LUNG CANCER AND CNS INVOLVEMENT
Coordinadores / Moderators: Dr. Alejandro Muggeri, Valeria Denninghoff
Disertante / Speaker: Dra. Maria E. Arcilia
14:30 - 15:00hs. (UTC-3)
ACTUALIZACIÓN DE TRATAMIENTO CON TÉCNICA SBRT SOBRE TUMORES CENTRALES / UPDATE ON STEREOTACTIC BODY RADIOTHERPY FOR CENTRAL TUMORS
Coordinador / Moderator: Dr. Máximo Barros
Disertante / Speaker: Dr. Matías Zapata
15:00 - 15:30hs. (UTC-3)
COFFEE BREAK
15:30 - 16:30hs. (UTC-3)
COMITÉ DE TUMORES / MULTIDISCIPLINARY TUMOR BOARD
Coordinadores / Moderators: Dres. Gerard Silvestri y Florencia Tsou
Disertantes / Speakers: Dres. Isabelle Opitz, Delvys Rodriguez Abreu, Maria E. Arcilia, David Smith, Diego Kaen y Máximo Barros
16:30 - 17:00hs. (UTC-3)
COMITÉ DE TUMORES MOLECULAR / MOLECULAR TUMOR BOARD
Coordinadora / Moderator: Dra. Delfina Peralta
Disertantes / Speakers: Dres. Gonzalo Recondo, Manglio Rizzo, Yanina Powasniak
CLAUSURA / CLOSING REMARKS
